Discontinued — last reported Q3 '21
Products & Services · Proceeds From License Agreement
Milestone Payments — Proceeds From License Agreement
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ3 2021
Last reportedQ3 2021
How to read this metric
An increase indicates successful execution of R&D or commercialization partnerships, while a decrease may suggest delays in project timelines or a lack of new licensing activity.
Detailed definition
This metric represents the cash inflows received from third-party partners upon the achievement of specific clinical, re...
Peer comparison
Common in biotech and life sciences firms; peers often report these as 'license revenue' or 'milestone revenue' under collaborative arrangements.
Metric ID:
ntra_segment_milestone_payments_proceeds_from_license_agreementHistorical Data
1 periods
| Q3 '21 | |
|---|---|
| Value | $1.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Natera, Inc.'s milestone payments — proceeds from license agreement?
- Natera, Inc. (NTRA) reported milestone payments — proceeds from license agreement of $1.00M in Q3 2021.
- What does milestone payments — proceeds from license agreement mean?
- Cash received from partners for hitting specific performance or development goals in a licensing deal.